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Abstract
The goal of this study was to identify single-locus and epistasis effects of SNP markers on anti-cyclic
citrullinated peptide (anti-CCP) that is associated with rheumatoid arthritis, using the North
American Rheumatoid Arthritis Consortium data. A square root transformation of the phenotypic
values of anti-CCP with sex, smoking status, and a selected subset of 20 single-nucleotide
polymorphism (SNP) markers in the model achieved residual normality (p > 0.05). Three single-
locus effects of two SNPs were significant (p < 10-4). The epistasis analysis tested five effects of each
pair of SNPs, the two-locus interaction, additive × additive, additive × dominance, dominance ×
additive, and dominance × dominance effects. A total of ten epistasis effects of eight pairs of SNPs
on 11 autosomes and the X chromosome had significant epistasis effects (p < 10-7). Three of these
epistasis effects reached significance levels of p < 10-8, p < 10-9, and p < 10-10, respectively. Two
potential SNP epistasis networks were identified. The results indicate that the genetic factors
underlying anti-CCP may include single-gene action and gene interactions and that the gene-
interaction mechanism underlying anti-CCP could be a complex mechanism involving pairwise
epistasis effects and multiple SNPs.
Background
The data set of the North American Rheumatoid Arthritis
Consortium (NARAC) for Genetic Analysis Workshop 15
(GAW15) contains genotypes of 5700 SNPs covering all
23 human chromosomes, affected status of rheumatoid
arthritis (RA), and a number of quantitative traits includ-
ing anti-cyclic citrullinated peptide (anti-CCP). Anti-CCP
is associated with RA and is used by some as a measure of
RA [1]. Linkage analysis of the RA status in the NARAC
data using affected sib-pair method has been reported [2].
Methods
The NARAC data set was edited by requiring each individ-
ual to have SNP genotypes on the 5700 SNPs and anti-
CCP record, and 1466 individuals satisfied this criterion.
The anti-CCP values significantly deviated from normal
distribution with p < 0.01 (Fig. 1A), according to the Sha-
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piro-Wilk, Kolmogorov-Smirnov, Cramer-von Mises, and
Anderson-Darling tests offered by SAS UNIVARIATE PRO-
CEDURE [3]. Because the residual normal distribution,
not the phenotypic normal distribution, is required for
the statistical tests in this article, a statistical model that
achieves residual normality was found using the proce-
dure leading to Figures 1B–1F. The untransformed anti-
CCP did not achieve residual normality (p < 0.01; Fig. 1B–
1C). The Box-Cox transformation [4] for a range of λ val-
ues and the square root transformation of anti-CCP were
evaluated to find an optimal transformation that has the
minimal sum of squares under the model for Figure 1B
and improves the residual normality. None of the trans-
formations achieved residual normality (p < 0.01), but the
square root transformation was found to have minimal
residual sum of squares. The residual distribution under
this transformation is shown in Figure 1D. For the model
used in Figure 1D, a total of 41 SNPs were found to have
significant single-locus and epistasis effects with the same
significance level as the SNPs for Figure 1C. Adding all the
41 SNPs in the model for Figure 1D achieved a near-per-
fect residual normality (p > 0.15; Fig. 1E). To reduce the
model degrees of freedom or increase the residual degrees
of freedom, step-wise elimination of SNPs from the full
model for Figure 1E was conducted to find the minimal
set of SNPs that had 20 SNPs (Table 1) and still achieved
residual normality for the transformed data (p > 0.05; Fig.
1F). In the model for Figure 1F, each SNP with a single-
locus effect was fitted in model as a locus with three gen-
otypes while each pair of SNPs were fitted in the model as
a genetic factor with nine (3 × 3) genotypes. Each SNP or
SNP pair in this subset was re-tested by treating the other
SNPs in the set as fixed effects (in addition to sex and
smoking status). For all SNPs not in this subset, the SNP
effects were tested based on the model for Figure 1F. The
model for testing single-locus effects was
(y)1/2 = sex + CigE + (normality SNPs) + SNP + e,
(1)
where (y)1/2 is the square root transformed anti-CCP, sex is
the gender of the individual, CigE is the indicator variable
whether the person ever smoked, (normality SNPs) is the
20 SNPs in Table 1 to achieve residual normality shown in
Figure 1F, SNP is the SNP being tested for three single-
locus effects (the SNP marker effect, and additive and
dominance effects), and e is the random residual. The sig-
nificance test of the SNP marker effect used an F-test, and
t-tests were used to test additive and dominance effects.
The epistasis analysis tested five effects of each pair of
SNPs: two-locus interaction (I), additive × additive (A ×
A), additive × dominance (A × D), dominance × additive
(D × A), and dominance × dominance (D × D) epistasis
effects. The genetic interpretation of the A × A, A × D, D ×
A, and D × D epistasis effects are allele × allele, allele ×
genotype, genotype × allele, and genotype × genotype
interactions, respectively. The model for testing epistasis
effects was
(y)1/2 = sex + CigE + (normality SNPs) + SNP1 + SNP2 + 
SNP1*SNP2 + e,( 2 )
where SNP1*SNP2 is the interaction effect between the
two SNPs, to be denoted by "I". The significance test of the
I-effect used an F-test, and t-tests were used to test four
individual epistasis effects, A × A, A × D, D × A, and D ×
D, using an extended Kempthorne model that allows
Hardy-Weinberg and linkage disequilibria [5]. The I-effect
Histograms of anti-CCP distributions Figure 1
Histograms of anti-CCP distributions. A-D significantly deviated from the normal distribution (p < 0.01). The deviations 
from normal distribution were insignificant in E (p > 0.15) and F (p > 0.05). A, Phenotypic distribution of anti-CCP values; B, 
residual distribution of anti-CCP values under the model with sex and smoking status as the fixed effects; C, residual distribu-
tion of anti-CCP values under the model with sex, smoking status, and all 37 SNPs with significant single-locus and epistasis 
effects as the fixed effects; D, residual distribution of the square root transformed anti-CCP values under the model with sex 
and smoking status as the fixed effects; E, residual distribution of the square root transformed anti-CCP values under the 
model with sex, smoking status, and all 41 SNPs with significant single-locus and epistasis effects as the fixed effects; F, residual 
distribution of the square root transformed anti-CCP values under the model with sex, smoking status, and a minimal subset of 
20 SNPs from the 41 SNPs in E, to achieve normality.BMC Proceedings 2007, 1(Suppl 1):S127 http://www.biomedcentral.com/1753-6561/1/S1/S127
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answers the question whether the two loci had an interac-
tion whereas an individual epistasis effect identifies the
exact mode of the interaction. For testing epistasis effects
involving the X chromosome, only females were included
in the analysis. The single-locus and epistasis tests using
Models (1–2) were implemented using the epiSNP com-
puter package developed by the authors [6].
Results
Significant single-locus SNP effects
The single-locus analysis using Model (1) had 17,100 tests
for 5700 SNPs. Two SNPs on chromosomes 2 and 3 had
three significant effects on the transformed data with p <
10-4 (Table 2). With the stringent significance level of p <
10-4, 17,100 tests are expected to yield 1.7 significant
results by chance. Therefore, the three significant effects of
two SNPs could be due to chance. Results with less strin-
gent significance levels may be of interest to compare with
reported results for possible confirmations. A total of 231
single-locus effects of all chromosomes were significant at
p < 0.01.
Significant epistasis effects
The epistasis analysis using Model (2) had 81,210,750
tests for 5700 SNPs. Ten significant epistasis effects of
eight pairs of SNPs on 11 autosomes and the X chromo-
some reached the significance level of p < 10-7 (Table 3).
Of these ten effects, three effects of two pairs of SNPs
reached significance levels of p < 10-8, p < 10-9, and p < 10-
10, respectively (Table 3). The most significant epistasis
effect was an additive × additive effect between two SNPs
on chromosome 11 and the X chromosome, followed by
a dominance × additive effect between chromosomes 7
and 10. With the significance level of p < 10-7, the expected
number of significant results out of 81,210,750 tests due
to chance is eight, so that ten observed significant epistasis
effects were more than expected by chance. More impor-
tantly, the three significant epistasis effects with p < 10-8, p
< 10-9, and p < 10-10 far exceeded the significance level
defined by the threshold p-value of 10-7 to be considered
as random results. Based on this analysis, evidence for
epistasis effects was stronger than single effects reported in
this article.
Complex gene interaction mechanism and epistasis 
network
The epistasis results indicate that the gene interaction
mechanism underlying anti-CCP could be a complex
mechanism involving three types of epistasis effects and
multiple SNPs, where 'three types of epistasis' refers to A ×
A, A × D or D × A, and D × D. The exact content of this
complex mechanism can be illustrated using the example
of three highly significant pairs of SNPs, rs1009172 (chro-
mosome 11) and rs17410 (chromosome X), rs2056553
(chromosome 7) and rs1328327 (chromosome 10), and
rs1400142 (chromosome 12) and rs1959068 (chromo-
some 14). The exact gene interaction mechanism of these
three pairs is (A × A)-(D × A)-(D × D). Close examination
of each of the three epistasis effects showed that individu-
als with 1_1 allele combination of rs1009172 (chromo-
some 11) and rs17410 (chromosome X) SNP pair, 22_2
genotype-allele combination of rs2056553 (chromosome
Table 1: Minimal set of SNPs to achieve residual normality of the square root transformed anti-CCP values in Figure 1F
Chromosome 2 SNP1 Chromosome 2 SNP2
2 rs2685263 -a -
6 rs1892512 - -
2 rs289847 16 rs9033
2 rs981395 23 rs1108444
3 rs13975 5 rs1016256
6 rs1398576 18 rs884205
8 rs1000236 9 rs751340
12 rs1400142 14 rs1959068
12 rs1843910 22 rs743409
14 rs1033594 17 rs759563
16 rs194790 17 rs1872076
a-, The left marker had a significant single-locus effect.
Table 2: Significant single-locus SNP effects on square root transformed anti-CCP with p < 10-4
Chromosome SNP Chromosome location (bp) Effect p-Value
2 rs1017267 539,873 Marker 0.525 × 10-4
2 rs1017267 539,873 Dominance 0.403 × 10-4
3 rs1401337 149,511,657 Marker 0.628 × 10-4BMC Proceedings 2007, 1(Suppl 1):S127 http://www.biomedcentral.com/1753-6561/1/S1/S127
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7) and rs1328327 (chromosome 10) SNP pair, and 11_12
genotype-genotype combination of rs1400142 (chromo-
some 12) and rs1959068 (chromosome 14) SNP pair had
the lowest square root transformed anti-CCP values. In
contrast, individuals with 1_2  allele combination of
rs1009172 (chromosome 11) and rs17410 (chromosome
X) SNP pair, 12_2  genotype-allele combination of
rs2056553 (chromosome 7) and rs1328327 (chromo-
some 10) SNP pair, and 11_11 genotype-genotype combi-
nation of rs1400142 (chromosome 12) and rs1959068
(chromosome 14) SNP pair had the highest square root
transformed anti-CCP values. In addition to highly signif-
icant epistasis effects, an epistasis network around a locus
that has a highly significant epistasis effect with at least
one locus and interacted with a large number of other loci
at a lower significance level (higher p-value) should be of
interest, because many significant epistasis effects involv-
ing one locus at a lower significance level are less likely to
be random than a single epistasis effect at the same signif-
icance level. Figure 2 shows two examples of such epistasis
network.
Discussion
The results showed that evidence for epistasis effects was
stronger than for single-locus effects on anti-CCP. This
implies that gene interactions could be an important
Two potential epistasis networks each centered at an SNP that had one of the most significant epistasis effects and interacted  with other loci at lower significance levels Figure 2
Two potential epistasis networks each centered at an SNP that had one of the most significant epistasis effects 
and interacted with other loci at lower significance levels. Each type of epistasis effect is represented by the line color: 
black, I effect; red, A × A; purple, A × D; blue, D × A; green, D × D. A pair of SNPs connected by two lines had two significant 
epistasis effects. The significance level of each epistasis effect is represented by the node color: red, p < 10-10; cyan, p < 10-7; 
green, p < 10-6; yellow, p < 10-5. A, Epistasis network centered at rs1009172 of chromosome 11; B, Epistasis network centered 
at rs1395610 of chromosome 18.
(A) (B)
Table 3: Significant SNP epistasis effects on square root transformed anti-CCP with p < 10-7
Chromosome 1 SNP1 Chromosome 2 SNP2 Effecta p-Value
1 rs2031750 18 rs1395610 A × A 0.827 × 10-7
2 rs1261238 23 rs953114 D × A 0.976 × 10-7
6 rs310389 13 rs4941527 I 0.563 × 10-7
6 rs310389 13 rs4941527 D × A 0.765 × 10-7
6 rs873460 16 rs874562 A × A 0.754 × 10-7
6 rs1087924 23 rs644429 I 0.583 × 10-7
7 rs2056553 10 rs1328327 D × A 0.583 × 10-8
11 rs1009172 23 rs17410 I 0.612 × 10-9
11 rs1009172 23 rs17410 A × A 0.247 × 10-10
12 rs1400142 14 rs1959068 D × D 0.437 × 10-7
aI, two-locus interaction effect; A × A, additive × additive effect; A × D, additive × dominance effect; D × A, dominance × additive effect; D × D, 
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genetic factor underlying rheumatoid arthritis. The phe-
notypic distribution of anti-CCP might merit further
study to identify factors that caused the distribution curve
with multiple peaks as shown in Figure 1A. Including such
factors in the statistical model could achieve residual nor-
mality without using as many 'normality SNPs' and hence
increases the residual degrees of freedom.
Conclusion
The genetic factors underlying anti-CCP may include sin-
gle-gene action and gene interactions but gene interaction
effects could be more important than single-gene effects.
The gene interaction mechanism could be a complex
mechanism involving a number of SNPs and three types
of pairwise epistasis effects, and the epistasis results could
be used to identify allelic and genotypic combinations
with the highest and lowest anti-CCP levels.
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